NCT00768495

Brief Summary

This trial will collect tissue oxygenation data via hyperspectral imaging before and after endovascular procedures.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2008

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2008

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

October 6, 2008

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 8, 2008

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2009

Completed
Last Updated

June 4, 2009

Status Verified

June 1, 2009

Enrollment Period

1.2 years

First QC Date

October 6, 2008

Last Update Submit

June 2, 2009

Conditions

Keywords

revascularizationclaudicationhyperspectraloxygenationlimb ischemia

Study Arms (1)

One Cohort

Eligibility Criteria

Age50 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who have chronic limb ischemia and present with the symptoms of claudication, rest pain or having minor non-healing ulcers or gangrene (Rutherford category 1 to 6) who also require percutaneous endovascular revascularization.

You may qualify if:

  • Patients with established diagnosis of lower limb ischemic based on their symptoms of claudication, rest pain, non-healing ulcers or gangrene and other vascular laboratory tests that are currently used to make this diagnosis and have been scheduled for endovascular revascularization.
  • Age group between 50-85
  • Gender - Male or Female
  • Race - all race and ethnicities

You may not qualify if:

  • Patients with known cardiac disease - new MI (within 3 months).
  • Patients with hypertension with the systolic BP \>200 or diastolic BP\>110 on the day of testing
  • Patients on supplemental O2 for chronic obstructive lung disease
  • Bed-ridden subjects - either due to chronic disability or neurological problems

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cardiac, Vascular & Thoracic Surgery Associates

Falls Church, Virginia, 22042, United States

RECRUITING

Related Publications (5)

  • Ostchega Y, Paulose-Ram R, Dillon CF, Gu Q, Hughes JP. Prevalence of peripheral arterial disease and risk factors in persons aged 60 and older: data from the National Health and Nutrition Examination Survey 1999-2004. J Am Geriatr Soc. 2007 Apr;55(4):583-9. doi: 10.1111/j.1532-5415.2007.01123.x.

    PMID: 17397438BACKGROUND
  • White C. Clinical practice. Intermittent claudication. N Engl J Med. 2007 Mar 22;356(12):1241-50. doi: 10.1056/NEJMcp064483. No abstract available.

    PMID: 17377162BACKGROUND
  • Yao ST. Haemodynamic studies in peripheral arterial disease. Br J Surg. 1970 Oct;57(10):761-6. doi: 10.1002/bjs.1800571016. No abstract available.

    PMID: 5476754BACKGROUND
  • Begelman SM, Jaff MR. Noninvasive diagnostic strategies for peripheral arterial disease. Cleve Clin J Med. 2006 Oct;73 Suppl 4:S22-9. doi: 10.3949/ccjm.73.suppl_4.s22.

    PMID: 17385388BACKGROUND
  • Raines JK, Darling RC, Buth J, Brewster DC, Austen WG. Vascular laboratory criteria for the management of peripheral vascular disease of the lower extremities. Surgery. 1976 Jan;79(1):21-9.

    PMID: 1246689BACKGROUND

Related Links

MeSH Terms

Conditions

Intermittent Claudication

Condition Hierarchy (Ancestors)

Peripheral Arterial DiseasePeripheral Vascular DiseasesVascular DiseasesCardiovascular DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Kevin Schomacker, PhD

    HyperMed

    STUDY DIRECTOR

Central Study Contacts

Kevin Scomacker, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

October 6, 2008

First Posted

October 8, 2008

Study Start

October 1, 2008

Primary Completion

December 1, 2009

Study Completion

December 1, 2009

Last Updated

June 4, 2009

Record last verified: 2009-06

Locations